SLC5A2 and transient ischemic attack: Although there was no beneficial effect on ischemic, TIA, non-fatal or fatal stroke, potential protection of SGLT2 inhibitors against hemorrhagic stroke was shown in pooled analysis of the different stroke subtypes, despite the small number of events.